TY - JOUR
T1 - Activation of Toll-like receptors induces macrophage migration via the iNOS/Src/FAK pathway
AU - Maa, Ming Chei
AU - Leu, Tzeng Horng
N1 - Funding Information:
This work was supported in part by grants from the National Science Council ( NSC 98-2311-B-039-002-MY3 to M.-C.M. ), National Health Research Institute ( NHRI-EX98-9828B1 to T.-H.L. ), and China Medical University ( CMU 99-S-07 to M.-C.M. ).
PY - 2011/12
Y1 - 2011/12
N2 - Macrophage motility is crucial in innate immunity. Toll-like receptors (TLRs), members of the interleukin-1 receptor superfamily, are a family of transmembrane pattern recognition receptors that are expressed primarily in antigen-expressing cells such as macrophages. These interleukin-1 receptors play a key role in immune response by recognizing highly conserved microbial molecules known as pathogen-associated molecular patterns. Studies have shown that when the macrophage-like cell line RAW264.7, peritoneal macrophages, and bone marrow-derived macrophages are exposed to lipopolysaccharide (LPS, TLR4 ligand), peptidoglycan (PGN, TLR2 ligand), polyinosinic-polycytidylic acid (polyI:C, TLR3 ligand), or CpG-oligodeoxynucleotides (CpG, TLR9 ligand), there is a marked increase in cell motility and in levels of activated Src (but not Fgr, Hck, and Lyn). Attenuation of Src suppressed LPS-, PGN-, polyI:C-, and CpG-elicited movement as well as the level of FAK Pi-Tyr861, which can be reversed by reintroduction of siRNA-resistant Src. Furthermore, siRNA knockdown of FAK decreased the degree of TLR-mediated motility of macrophages. Strikingly, LPS-, PGN-, polyI:C-, and CpG-enhanced Src expression, FAK Pi-Tyr861, and cell motility were greatly reduced in macrophages devoid of inducible nitric oxide synthase (iNOS, a NF-κB target), which can be induced by the aforementioned TLR ligands. Because NO can upregulate the expression and activity of Src, and because Src can mediate NF-κB activation, we hypothesize that there is a loop of signal amplification that influences the iNOS/Src/FAK axis for macrophage locomotion in response to engagement of TLRs.
AB - Macrophage motility is crucial in innate immunity. Toll-like receptors (TLRs), members of the interleukin-1 receptor superfamily, are a family of transmembrane pattern recognition receptors that are expressed primarily in antigen-expressing cells such as macrophages. These interleukin-1 receptors play a key role in immune response by recognizing highly conserved microbial molecules known as pathogen-associated molecular patterns. Studies have shown that when the macrophage-like cell line RAW264.7, peritoneal macrophages, and bone marrow-derived macrophages are exposed to lipopolysaccharide (LPS, TLR4 ligand), peptidoglycan (PGN, TLR2 ligand), polyinosinic-polycytidylic acid (polyI:C, TLR3 ligand), or CpG-oligodeoxynucleotides (CpG, TLR9 ligand), there is a marked increase in cell motility and in levels of activated Src (but not Fgr, Hck, and Lyn). Attenuation of Src suppressed LPS-, PGN-, polyI:C-, and CpG-elicited movement as well as the level of FAK Pi-Tyr861, which can be reversed by reintroduction of siRNA-resistant Src. Furthermore, siRNA knockdown of FAK decreased the degree of TLR-mediated motility of macrophages. Strikingly, LPS-, PGN-, polyI:C-, and CpG-enhanced Src expression, FAK Pi-Tyr861, and cell motility were greatly reduced in macrophages devoid of inducible nitric oxide synthase (iNOS, a NF-κB target), which can be induced by the aforementioned TLR ligands. Because NO can upregulate the expression and activity of Src, and because Src can mediate NF-κB activation, we hypothesize that there is a loop of signal amplification that influences the iNOS/Src/FAK axis for macrophage locomotion in response to engagement of TLRs.
UR - http://www.scopus.com/inward/record.url?scp=84861193419&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84861193419&partnerID=8YFLogxK
U2 - 10.1016/j.biomed.2011.10.002
DO - 10.1016/j.biomed.2011.10.002
M3 - Review article
AN - SCOPUS:84861193419
SN - 2211-8020
VL - 1
SP - 11
EP - 15
JO - BioMedicine (Taiwan)
JF - BioMedicine (Taiwan)
IS - 1
ER -